MedPath

Evaluation of Feasibility of Radiofrequency Ablation Using Electrodes with Temperature Monitoring and Drug Infusion for Malignant Liver Tumors

Not Applicable
Conditions
Neoplasms
Registration Number
KCT0007332
Lead Sponsor
Seoul National University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

(1) Patients who agreed to participate in this study.
(2) Age 20~85 yrs.
(3) Child-Pugh Class A or B.
(4) Patients with cirrhosis who are considering radiofrequency ablation for suspected malignant liver tumors with a size of 2 cm or less on MDCT, CEUS, or MRI performed within 60 days

Exclusion Criteria

(1) number of tumors, equal or more than three.
(2) maximal diameter of tumor, over 2 cm.
(3) diffuse infiltrative type cancer.
(4) tumors contacting portal vein or hepatic vein (equal or more than 5 mm) or bile duct.
(5) Child-Pugh class B8 or C
(6) Presence of vascular invasion by tumor
(7) Platelet count, equal or less than 50,000/mm3 or PT prolongation (=50%).
(8) Presence of multiple extrahepatic metastases.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Whether or not the temperature measurement was successful in the tissue surrounding the tumor at 3 minutes, 6 minutes and at the end of the radiofrequency ablation
Secondary Outcome Measures
NameTimeMethod
Evaluate whether the impedance can be reduced, more than 10% by injecting normal saline into the liver parenchyma when the impedance increases rapidly during the radiofrequenchy ablation, making it difficult to transmit energy.
© Copyright 2025. All Rights Reserved by MedPath